MedTrace Logo

STREAMLINE®SURGICAL SYSTEM Compared to iStent Inject W® in Patients With Open-Angle Glaucoma

NCT05280366 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2024-11-12

No results posted yet for this study

Summary

A study of the Streamline Surgical System versus competitor

Conditions

Interventions

DEVICE

Streamline Surgical System

Completion of the Streamline Surgical System procedure

DEVICE

iStent Inject W

Implantation of competitor device

Sponsors & Collaborators

  • New World Medical, Inc.

    lead INDUSTRY

Principal Investigators

  • Elysia Ison, OD · New World Medical, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-09
Primary Completion
2026-06-30
Completion
2026-06-30
FDA Device
Yes

Countries

  • United States
  • Costa Rica
  • Mexico

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05280366 on ClinicalTrials.gov